Search

Author/Creator Baumgart, D. C.

1. Ferric maltol therapy for iron deficiency anaemia in patients with inflammatory bowel disease: long‐term extension data from a Phase 3 study. Issue 3 (29th May 2016)

Authors:
Schmidt, C.; Ahmad, T.; Tulassay, Z.; Baumgart, D. C.; Bokemeyer, B.; Howaldt, S.; Stallmach, A.; Büning, C.
Other Names:
Baumgart Daniel C. investigator.; Bokemeyer Bernd investigator.; Büning Carsten investigator.; Helwig Ulf investigator.; Howaldt Stefanie investigator.; Hüppe Dietrich investigator.; Krummenerl Annette investigator.; Krummenerl Thomas investigator.; Kühbacher Tanja investigator.; Landry Wilfried ...
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 44:Issue 3(2016)
Page Start:
259
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Vedolizumab induction therapy for inflammatory bowel disease in clinical practice – a nationwide consecutive German cohort study. Issue 10 (1st April 2016)

Authors:
Baumgart, D. C.; Bokemeyer, B.; Drabik, A.; Stallmach, A.; Schreiber, S.
Other Names:
Atreya Raya investigator.; Bachmann Oliver investigator.; Busse Karin investigator.; Bläker Michael investigator.; Börner Norbert investigator.; Büning Jürgen investigator.; Dignass Axel investigator.; Ehehalt Robert investigator.; Ende Karin investigator.; Fischer Andreas investigator.; Jessen P...
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 43:Issue 10(2016)
Page Start:
1090
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease – a prospective multicenter observational study. Issue 11 (7th October 2016)

Authors:
Stallmach, A.; Langbein, C.; Atreya, R.; Bruns, T.; Dignass, A.; Ende, K.; Hampe, J.; Hartmann, F.; Neurath, M. F.; Maul, J.; Preiss, J. C.; Schmelz, R.; Siegmund, B.; Schulze, H.; Teich, N.; von Arnim, U.; Baumgart, D. C.; Schmidt, C.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 44:Issue 11/12(2016)
Page Start:
1199
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease – a prospective multicenter observational study. Issue 11 (7th October 2016)

Authors:
Stallmach, A.; Langbein, C.; Atreya, R.; Bruns, T.; Dignass, A.; Ende, K.; Hampe, J.; Hartmann, F.; Neurath, M. F.; Maul, J.; Preiss, J. C.; Schmelz, R.; Siegmund, B.; Schulze, H.; Teich, N.; von Arnim, U.; Baumgart, D. C.; Schmidt, C.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 44:Issue 11/12(2016)
Page Start:
1199
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗